BARCELONA, Spain--(BUSINESS WIRE)--INBRAIN Neuroelectronics S.L., a company in the intersection between Medtech, Deeptech and Digital Health dedicated to developing the world’s first intelligent ...

With over 30 years' experience, Dr. Véronique Foutel has played a key role in bringing to market several significant medical advances such as the first monoclonal antibodies in oncology (MABTHERA, ...

Image caption: INBRAIN Cortical BCI; Image credit: INBRAIN Neuroelectronics Graphene-based BCI demonstrates high-resolution brain decoding and mapping in patients undergoing tumor resection at the ...

Spain-based INBRAIN Neuroelectronics, a company specialising in graphene-based brain-computer interface (BCI) technologies, has secured $50m (€46m) in a Series B financing round, aimed at advancing ...

INBRAIN Neuroelectronics, a neurotechnology company developing graphene-based brain-computer interface therapeutics (BCI-Tx), today announced completion of patient recruitment in its first-in-human ...

Barcelona-based INBRAIN Neuroelectronics, which offers a graphene-based brain-computer interface (BCI) therapeutics platform, announced a strategic partnership with tech giant Microsoft to advance the ...

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance the Spanish company’s graphene-based brain-computer interface (BCI) technology. Inbrain ...

Funding supports neuroelectronic technologies as part of national strategy to boost Spain's microelectronics and semiconductor industry INBRAIN Neuroelectronics, a clinical-stage neurotechnology ...

The study (NCT06368310), sponsored by the University of Manchester and conducted with Northern Care Alliance NHS Foundation Trust, evaluated INBRAIN’s graphene-based cortical interface during ...